Effects of propofol on renal ischemia/reperfusion injury in rats

Experimental and Therapeutic Medicine

Volumn 6, Issue 5, 2013, Pages 1177-1183

  Yang, Shun ^a   Chou, Wei Ping ^b   Pei, Ling ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Bone morphogenetic protein 2; Ischemia reperfusion injury; Kidney; Propofol

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CREATININE; INTERLEUKIN 6; INTERLEUKIN 8; MALONALDEHYDE; PROPOFOL; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG MEGADOSE; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; KIDNEY FUNCTION TEST; KIDNEY ISCHEMIA; KIDNEY TUBULE NECROSIS; LIPID PEROXIDATION; LOW DRUG DOSE; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

EID: 84884772257     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1305     Document Type: Article

References (42)

1. Bonventre JV and Zuk A: Ischemic acute renal failure: an inflammatory disease? Kidney Int 66: 480-485, 2004.
2. Thurman J.M.: Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol 123: 7-13, 2007.
3. Ysebaert DK, De Greef KE, De Beuf A, et al: T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 66: 491-496, 2004.
4. Erdogan H, Fadillioglu E, Yagmurca M, Ucar M and Irmak MK: Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res 34: 41-46, 2006.
5. Li XL, Zou XM, Gao P, Li YL, Wang H and Chen XW: Role of nitric oxide in ischemia-reperfusion injury and acute rejection in rat intestinal transplantation. Transplant Proc 40: 3342-3345, 2008.
6. Xia Z, Godin DV, Chang TK and Ansley DM: Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation. Can J Physiol Pharmacol 81: 14-21, 2003.
7. Javadov SA, Lim KH, Kerr PM, Suleiman MS, Angelini GD and Halestrap AP: Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 45: 360-369, 2000.
8. Kokita N, Hara A, Abiko Y, Arakawa J, Hashizume H and Namiki A: Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth Analg 86: 252-258, 1998.
9. Yang CY, Wong CS, Yu CC, Luk HN and Lin CI: Propofol inhibits cardiac L-type calcium current in guinea pig ventricular myocytes. Anesthesiology 84: 626-635, 1996.
10. Zhou W, Fontenot HJ, Liu S and Kennedy RH: Modulation of cardiac calcium channels by propofol. Anesthesiology 86: 670-675, 1997.
11. Jordan JE, Zhao ZQ and Vinten-Johansen J: The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43: 860-878, 1999.
12. Simpson PJ, Fantone JC, Mickelson JK, Gallagher KP and Lucchesi BR: Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion. Circ Res 63: 1070-1079, 1988.
13. Shin IW, Lim BW, Chung YS, et al: The effect of propofol on myocardial protection after regional ischemia-reperfusion injury in an in vivo rat heart model. Korean J Anesthesiol 55: 338-343, 2008.
14. Nauth A, Ristiniemi J, McKee MD and Schemitsch EH: Bone morphogenetic proteins in open fractures: past, present, and future. Injury 40 (Suppl 3): S27-S31, 2009.
15. El-Bizri N, Guignabert C, Wang L, et al: SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis. Development 135: 2981-2991, 2008.
16. Hansmann G, de Jesus Perez VA, Alastalo TP, et al: An antipro-liferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest 118: 1846-1857, 2008.
17. Wybenga DR, Di Giorgio J and Pileggi VJ: Manual and automated methods for urea nitrogen measurement in whole serum. Clin Chem 17: 891-895, 1971.
18. Kueltzo LA, Ersoy B, Ralston JP and Middaugh CR: Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study. J Pharm Sci 92: 1805-1820, 2003.
19. Paller MS, Hoidal JR and Ferris TF: Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 74: 1156-1164, 1984.
20. Morsy MD, Mostafa OA and Hassan WN: A potential protective effect of alpha-tocopherol on vascular complication in spinal cord reperfusion injury in rats. J Biomed Sci 17: 55, 2010.
21. Sasaki M and Joh T: Oxidative stress and ischemia-reperfusion injury in gastrointestinal tract and antioxidant, protective agents. J Clin Biochem Nutr 40: 1-12, 2007.
22. van der Heijden M, Versteilen A M, Sipkema P, van Nieuw Amerongen GP, Musters RJ and Groeneveld AB: Rho-kinase-dependent F-actin rearrangement is involved in the inhibition of PI3-kinase/Akt during ischemia-reperfusion-induced endothelial cell apoptosis. Apoptosis 13: 404-412, 2008.
23. Bayrak O, Turgut F, Karatas OF, et al: Oral beta-glucan protects kidney against ischemia/reperfusion injury in rats. Am J Nephrol 28: 190-196, 2008.
24. Schramm L, Weierich T, Heldbreder E, Zimmermann J, Netzer KO and Wanner C: Endotoxin-induced acute renal failure in rats: effects of L-arginine and nitric oxide synthase inhibition on renal function. J Nephrol 18: 374-381, 2005.
25. Spek CA, Brüggemann LW and Borensztajn K S: Protease-activated receptor 2 blocking peptide counteracts endotoxin-induced inflammation and coagulation and ameliorates renal fibrin deposition in a rat model of acute renal failure. Shock 33: 339; author reply 339-340, 2010.
26. Petronijević ND, Mićić DV, Duricić B, Marinković D and Paunović VR: Substrate kinetics of erythrocyte membrane Na,K-ATPase and lipid peroxides in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27: 431-440, 2003.
27. Kato R and Foëx P: Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Can J Anaesth 49: 777-791, 2002.
28. Jin YC, Kim W, Ha YM, et al: Propofol limits rat myocardial ischemia and reperfusion injury with an associated reduction in apoptotic cell death in vivo. Vascul Pharmacol 50: 71-77, 2009.
29. Sánchez-Conde P, Rodriguez-López JM, Nicolás JL, et al: The comparative abilities of propofol and sevoflurane to modulate inflammation and oxidative stress in the kidney after aortic cross-clamping. Anesth Analg 106: 371-378, 2008.
30. Yuzbasioglu MF, Aykas A, Kurutas EB and Sahinkanat T: Protective effects of propofol against ischemia/reperfusion injury in rat kidneys. Ren Fail 32: 578-583, 2010.
31. Yuzer H, Yuzbasioglu MF, Ciralik H, et al: Effects of intravenous anesthetics on renal ischemia/reperfusion injury. Ren Fail 31: 290-296, 2009.
32. Dhore CR, Cleutjens JP, Lutgens E, et al: Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21: 1998-2003, 2001.
33. Sorescu GP, Song H, Tressel SL, et al: Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ Res 95: 773-779, 2004.
34. Shin V, Zebboudj AF and Boström K: Endothelial cells modulate osteogenesis in calcifying vascular cells. J Vasc Res 41: 193-201, 2004.
35. Sorescu GP, Sykes M, Weiss D, et al: Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J Biol Chem 278: 31128-31135, 2003.
36. Abe J: Bone morphogenetic protein (BMP) family, SMAD signaling and Id helix-loop-helix proteins in the vasculature: the continuous mystery of BMPs pleiotropic effects. J Mol Cell Cardiol 41: 4-7, 2006.
37. Csiszar A, Lehoux S and Ungvari Z: Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression. Antioxid Redox Signal 11: 1683-1697, 2009.
38. Ten Dijke P, Goumans MJ, Itoh F and Itoh S: Regulation of cell proliferation by Smad proteins. J Cell Physiol 191: 1-16, 2002.
39. Funaki C, Hodges RR and Dartt DA: Role of cAMP inhibition of p44/p42 mitogen-activated protein kinase in potentiation of protein secretion in rat lacrimal gland. Am J Physiol Cell Physiol 293: C1551-C1560, 2007.
40. Csiszar A, Ahmad M, Smith KE, et al: Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype. Am J Pathol 168: 629-638, 2006.
41. Csiszar A, Smith KE, Koller A, Kaley G, Edwards JG and Ungvari Z: Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation 111: 2364-2372, 2005.
42. Yang YL, Ju HZ, Liu SF, et al: BMP-2 suppresses renal interstitial fibrosis by regulating epithelial-mesenchymal transition. J Cell Biochem 112: 2558-2565, 2011.